arrow_back Trending Legislation
Share share

Increased Funding for Charcot-Marie-Tooth Disease Research

This House of Representatives resolution highlights the significance of Charcot-Marie-Tooth disease (CMT), affecting thousands of Americans, and calls for increased research funding. The aim is to accelerate the search for a cure and better treatments, potentially improving the quality of life for those suffering from this rare condition.
Key points
Recognizing Charcot-Marie-Tooth disease as a significant condition impacting many people.
Calling for robust funding for CMT research at the National Institute of Neurological Disorders and Stroke.
Emphasizing the need for continued investment in research for rare diseases with no cure.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Recognizing the significance of Charcot-Marie-Tooth disease and the need for robust funding of the National Institute of Neurological Disorders and Stroke at the National Institutes of Health.
Print number: HRES 1039
Sponsor: Rep. Gottheimer, Josh [D-NJ-5]
Process start date: 2024-02-29
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch
Summary & Status

Key Questions about Increased Funding for Charcot-Marie-Tooth Disease Research

A structured overview of the legislative process, official sources, status and civic context.

What is the official ID of this bill?

The official print number for this legislation is HRES 1039.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2024-02-29.

What are the main provisions?

Key points include:

  • Recognizing Charcot-Marie-Tooth disease as a significant condition impacting many people.
  • Calling for robust funding for CMT research at the National Institute of Neurological Disorders and Stroke.
  • Emphasizing the need for continued investment in research for rare diseases with no cure.

What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Gottheimer, Josh [D-NJ-5].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-24.

Analysis and Potential Impact of HRES 1039

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

CATEGORIES

Health